The RTW Podcast
Episodes
Biotech’s Next Era: Innovation and Commercialization
12 Jan 2026
Contributed by Lukas
Rod Wong joins Stephanie Sirota to trace biotech's evolution. What forces built today’s innovation landscape, and what might the next decade reveal?...
The Split Vote: UroGen and the FDA
01 Dec 2025
Contributed by Lukas
When an FDA panel held her company’s future in the balance, UroGen Pharma CEO Liz Barrett refused to fold, even with the odds stacked, a plunging st...
14 Months to Treatment: Breaking Records in Rare Disease Therapy
06 Oct 2025
Contributed by Lukas
From a Thanksgiving night emergency to one of the fastest gene therapies ever deployed, this is the story of a family’s relentless pursuit to help t...
Losing Sleep and Lives: Matthew Walker on the Global Sleep Epidemic
15 Sep 2025
Contributed by Lukas
Lack of sleep can be deadly and costly. Matthew Walker, author of NYT bestseller Why We Sleep and Stephanie Sirota explore the science of sleep, how n...
From drop to double: Akero’s surging stock
14 Jul 2025
Contributed by Lukas
When Akero’s stock dropped after a trial setback, why did RTW double down that same day? CEO Andrew Cheng joins RTW’s Rod Wong to share how he nav...
Ditching Delay: GH001’s Instant Impact on Depression
05 May 2025
Contributed by Lukas
Connor Williams was shocked when the data came back for GH001. What could this mean for the future of treatment-resistant depression? Listen to his ex...
Changing Minds: Psychedelics as Legitimate Medicine
07 Apr 2025
Contributed by Lukas
If you’re dismissing psychedelics in pharma, think again. Stephanie Sirota and Connor Williams discuss overcoming stigma and regulatory challenges, ...
Inside the clinic: GLP-1s with Dr. Rekha B. Kumar
22 Jan 2025
Contributed by Lukas
Dr. Rekha Kumar, Chief Medical Officer at Found, and Stephanie Sirota explore Rekha’s rise from academia, and her passion for obesity medicine. As n...
The $1 trillion GLP-1 revolution with Rod Wong
06 Jan 2025
Contributed by Lukas
Rod Wong and Stephanie Sirota delve into the transformative potential of GLP-1 drugs, focusing on their impact on obesity and related diseases. Rod sh...
Revolutionizing RNA therapeutics - Avidity Biosciences
12 Aug 2024
Contributed by Lukas
Sarah Boyce from Avidity Biosciences and Piratip Pratumsuwan from RTW Investments explore the strategic decisions and innovations that have driven Avi...
The power of partnership – Prometheus Biosciences
01 Dec 2023
Contributed by Lukas
Mark McKenna from Prometheus Biosciences and Josh Kennedy-Smith from RTW Investments tell us about the white-knuckle ride that is building a pharmaceu...